Massimo De Giorgio - Concepedia

Author

Massimo De Giorgio

Ospedale Papa Giovanni XXIII

Also Known As

M De Giorgio, M. De Giorgio, M. de Giorgio, M.-R. Taskinen, Massimo De Giorgio

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Ospedale Papa Giovanni XXIII Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Ospedale Maggiore Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan

About

Massimo De Giorgio is an author at Ospedale Papa Giovanni XXIII specializing in hepatology, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	507
2	Hepatology	4	4	507
3	Pathology	4	4	507
4	Health Sciences	1	1	149
5	Surgical Oncology	1	1	314

Massimo De Giorgio

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic and Prognostic Role of alpha-Fetoprotein in Hepatocellular Carcinoma: Both or Neither? Fabio Farinati, Dario Marino, Massimo De Giorgio, The American Journal of Gastroenterology	2006	411
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial Vincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori, The Lancet Oncology Surgical OncologyTransplantationHepatologyTumour DownstagingMedicine	2020	314
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis Tiziana Pressiani, C. Boni, Lorenza Rimassa, Annals of Oncology HepatologyMedicineLiver PhysiologyHistopathologyPathology	2012	149
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation Massimo Iavarone, Federica Invernizzi, Carolin Czauderna, American Journal of Transplantation	2019	85
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria Massimo De Giorgio, Stefano Vezzoli, Eric Cohen, Liver Transplantation	2010	42
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study Massimo Iavarone, Federica Invernizzi, Tommy Ivanics, Liver Transplantation Regorafenib EfficacyHcc RecurrenceTransplantationOncologyHepatology	2021	34
Small Hepatocellular Carcinomas and Thrombocytopenia Brian I. Carr, Vito Guerra, Massimo De Giorgio, Oncology	2012	26
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation Kyunghye Bang, Andrea Casadei‐Gardini, Changhoon Yoo, Cancer Medicine	2022	24
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments Francesco Tovoli, Dante Pio Pallotta, Vito Sansone, Transplantation	2022	11
Small HCCs Identified by Screening Petr Pančoška, Massimo De Giorgio, S. Fagiuoli, Digestive Diseases and Sciences HepatologyMedicineDiagnostic TestSmall Hccs IdentifiedHistopathology	2011	10

Page 1